Verified Nov 2026
Other
·

Santa Rosa, California
·
Since 1992
Rhevera Medical, formerly Endologix, is a medical device company headquartered in Santa Rosa, California, founded in 1992. It employs between 500 and 1,000 people, is publicly listed under the ticker ELGX, and serves the medical, automotive, electric-vehicle and industrial equipment sectors. The company develops endovascular therapies for vascular disease, including the DETOUR System for peripheral arterial disease and the ALTO Abdominal Stent Graft System for abdominal aortic aneurysms. It rebranded from Endologix in October 2026.
Rhevera Medical at a glance
Revenue
114M
Employees
500-1,000
Founded
1992
Headquarters
Santa Rosa, California
Ownership
Publicly traded (NASDAQ: ELGX)
Certifications
ISO 13485
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
STABILITY SIGNALS
Established & strong
34 years in operation (founded 1992).
Publicly listed; no distress event on record.
Holds ISO 13485 certification(s) per public sources.
Overview
Rhevera Medical, formerly Endologix, is a medical device company headquartered in Santa Rosa, California, founded in 1992. It employs between 500 and 1,000 people, is publicly listed under the ticker ELGX, and serves the medical, automotive, electric-vehicle and industrial equipment sectors. The company develops endovascular therapies for vascular disease, including the DETOUR System for peripheral arterial disease and the ALTO Abdominal Stent Graft System for abdominal aortic aneurysms. It rebranded from Endologix in October 2026.
At a glance
Attribute | Detail |
|---|---|
Founded | 1992 |
Headquarters | Santa Rosa, California |
Employees | 500-1,000 |
Revenue | 114M |
Ownership | Publicly traded (NASDAQ: ELGX) |
Certifications | ISO 13485 |
What Rhevera Medical makes
Its commercial vascular products include the DETOUR System, ALTO Abdominal Stent Graft System, AFX2 Endovascular AAA System and Pounce Thrombectomy System, and its manufacturing operates under ISO 13485 certification.
Certifications
Rhevera Medical is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — linkedin.com
Latest developments
2026-10-08 — Our first VIVA as Rhevera Medical | Luigi De Gennaro (linkedin.com)
2026-10-06 — Endologix is now Rhevera Medical (massdevice.com)
2026-10-06 — Endologix rebrands as Rhevera Medical (vascularnews.com)
2026-10-06 — Endologix rebrands as Rhevera Medical - Interventional News (interventionalnews.com)
2026-10-05 — Endologix Rebrands as Rhevera Medical (businesswire.com)
2026-10-05 — Endologix Rebrands as Rhevera Medical - Endovascular Today (evtoday.com)
Company details
Rhevera Medical Holdings is the parent of Endologix LLC, which is the legal manufacturer of the company's devices. Rhevera Medical was founded in 1992, has an estimated 500-1,000 employees, and is headquartered in Santa Rosa, California. On the LightSource stability read it is rated "Established & strong": 34 years in operation (founded 1992). Publicly listed; no distress event on record. Holds ISO 13485 certification(s) per public sources.
Frequently asked questions
What does Rhevera Medical do?
Rhevera Medical, formerly Endologix, is a medical device company headquartered in Santa Rosa, California, founded in 1992. It employs between 500 and 1,000 people, is publicly listed under the ticker ELGX, and serves the medical, automotive, electric-vehicle and industrial equipment sectors. The company develops endovascular therapies for vascular disease, including the DETOUR System for peripheral arterial disease and the ALTO Abdominal Stent Graft System for abdominal aortic aneurysms. It rebranded from Endologix in October 2026.
Where is Rhevera Medical headquartered?
Rhevera Medical is headquartered in Santa Rosa, California (3910 Brickway Blvd, Santa Rosa, California, 95403-1070).
When was Rhevera Medical founded?
Rhevera Medical was founded in 1992.
How big is Rhevera Medical?
Rhevera Medical has an estimated 500-1,000 employees, with revenue in the 114M range.
Is Rhevera Medical publicly traded?
Publicly traded (NASDAQ: ELGX). Public financial figures are drawn from its filings.
What certifications does Rhevera Medical hold?
Rhevera Medical lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
